36 matches found.
Click here, RED, 8>1>3, Methotrexate 10mg tablets, Non-proprietary, Malignancy
URL: /elmmb-formulary/joint-medicines-formulary/index-search/?EntryId14=14183
Click here, RED, 10>1>3, Metoject®, Malignancy, immuno- suppression, Methotrexate pre-filled syringe
URL: /elmmb-formulary/joint-medicines-formulary/index-search/?EntryId14=14383
Golimumab, Simponi®, Methotrexate naive patients with Rheumatoid Arthritis (NICE TA224), Black traffic light, BLACK, Click here
URL: /elmmb-formulary/joint-medicines-formulary/index-search/?EntryId14=14322
Malignancy, immuno- suppression, Non-proprietary, Methotrexate 2.5mg tablets, 8>1>3, AMBER shared care, Red for 10mg tabs & injection, Click here
URL: /elmmb-formulary/joint-medicines-formulary/index-search/?EntryId14=13873
Moderate rheumatoid arthritis after conventional DMARDs have failed [with methotrexate] - as per NICE TA715, 10>1>3, CCG Commissioned [See - 'Rheumatoid Arthritis Recommended High-Cost Drugs Pathway']...
URL: /elmmb-formulary/joint-medicines-formulary/index-search/?EntryId14=23566
10.1.3 Drugs which suppress the rheumatic disease process
Last Modified: 15/11/2022
Black Traffic Light Drugs (Not Recommended for Use)
Last Modified: 07/02/2023
Appendix 6 - Medicines not classified in the BNF – Imported or Unlicensed Products
Last Modified: 24/09/2021
NPSA Methotrexate Patient Briefing.pdf
Last Modified: 21/06/2016
Last Modified: 26/05/2016
